Dr Eric Meldrum

Biography

• Responsible for the strategy and operational management of pre-clinical drug discovery and development • Specialist in drug development, having worked for major pharmaceutical groups and biotechnology companies • Former Chief Scientific Officer at Genkyotex and at 3V Biosciences, where he developed portfolios of NOX-inhibiting molecules and of molecules targeting the replication of respiratory viruses respectively • Former Director of the Asthma Disease Biology Department at GSK, where he was accountable for the biology associated with more than a dozen drug research and development programmes through to Phase 2 of clinical trials

Research Interest

drug discovery and development